Complement sC5b-9 and CH50 increase the risk of cancer-related mortality in patients with non-small cell lung cancer

Objectives: Immunologic dysfunction occurred in most of patients with non-small cell lung cancer (NSCLC), which worsened the overall survival (OS) of patients. Complement activation plays a significant role in abnormal activation of immune system. However, the prognostic value of complement componen...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Cao, Zhijun, Mi, Lijie, Xu, Zhihua, Wu, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646172/
https://www.ncbi.nlm.nih.gov/pubmed/33193878
http://dx.doi.org/10.7150/jca.46721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646172/
https://www.ncbi.nlm.nih.gov/pubmed/33193878
http://dx.doi.org/10.7150/jca.46721

Ejemplares similares